We are AvenueBio

a dedicated strategy & integrated planning consultancy

AvenueBio was founded in 2017 with a single-minded focus on improving strategy development in pharma. For too long, we saw the immense value of collaborative strategy development being overlooked, and the resulting impact for patients and families needing new and better medicines.

Our passionate team is on a mission to transform biopharma strategy development, integrated planning, and cross-functional team effectiveness. We achieve this through vigorous and inquisitive analysis and application of excellence in collaborative teamwork. We push teams to get beyond generic pharma content, supporting them to make courageous strategic choices grounded in precision thinking, and to create clarity for all those involved in delivery.

Reasons to believe in us…

We set teams up for real success

Our imperative is to deliver meaningful work that brings out the best in teamsgoing the extra mile for our clients and creating outputs which resonate when shared with leadership and colleagues.

We continually seek ways to add value, ensuring we consider the broader context and implementation, so teams create momentum from our engagement for long-term success

We lead bolder, better thinking

Our team has had decades of diverse interactions and experiences with clients as colleagues, collaborative partners, and, in many cases, as friends. This gives our team the insight, knowledge and confidence to have real conversations and challenge established thoughts respectfully and ensure bolder, better thinking

We know rigour and details matter

In biopharma, details don’t just matter; they’re often the key that unlocks success for a team. In every project we dedicate ourselves to carefully comb through all resources available to us, capture team comments diligently, interrogate the real question behind each question, and call-out unique prospects and implications as we see them

We connect to the bigger picture

It is a privilege to be asked back again and again by client teams, and with that comes an inherent responsibility to ensure cohesion of ideas and projects over time. We are always mindful of how a decision today may have lasting impact on cross-functional teams, future development plans, and ultimately the disease landscape, patients and families

We cover an extensive range of therapy areas

Over the years we’ve touched on nearly all therapeutic areas and an extensive list of rare diseases. We strive to translate the learnings from one therapy area to the next as issues and opportunities are often analogous with adaptable solutions

Meet the team

Every project with AvenueBio is led by a senior team with decades of experience in strategy development and integrated planning. We align our team’s experience with the needs of our clients, ensuring the right talent to task, personality fit, and expertise to deliver high-quality partnerships. We share with clients and their teams our aspiration to always reach beyond the obvious answer, toward truly meaningful strategic choices and solutions that have lasting impact.

Michael Craig

Founder & Managing Director

Alasdair Williams

Vice President, Head of Consulting Operations

Anita Martin

Finance Director

Joanna Nield

Chief of Staff

Saskia Fontein

Vice President

Tracy Baker

Principal

Mike Parry

Principal

Hassan Choudhury

Principal

Jess Ford

Associated Partner

Russell Powter

Associated Partner

Karen Stoddart

Engagement Manager

Jaimee (Everitt) Foley

Managing Consultant

Jamie Mallinson

Managing Consultant

Mark Isbell

MANAGING Consultant

Angie Gao

Senior Consultant

Katie Cudmore

Senior Consultant

Andrew Nicholas

Senior Consultant

Pallavi Nigam

Senior Consultant

Sophie Priest

Consultant

Michelle Keller

Consultant

Joanna Myślińska

Associate Consultant

Peter Wallace

Consultant

Lily Ambler

Analyst

Claire Cook

Creative Manager

Miles Buzzing

Head of IT

Katie Schreiber

Projects Planner

Global to local. Function by Function. Pharmaceutical & Biotech Thinking Partners.